Clinical trials for Ebola drug to start on patients next month

As Ebola continues to rage through West Africa with a slowing down in Liberia but an upsurge in Sierra Leone, one death in Mali and a Nebraska hospital accepting a medical doctor married to a US citizen, clinical trials for Ebola drugs will start on patients suffering from the deadly disease from next month.
According to reports from Medicins Sans Frontieres (Doctors without Borders) up to three treatment centres will be the location for various research projects to stem the tide of this virulent illness that has killed 5000 people in Guinea, Liberia, Sierra Leone and Nigeria.
One trial involve taking the blood of previously infected and now recovered patients to treat sick people in Guinea. Other antiviral drugs are being tested in a secret location in Guinea.
“This is an unprecedented international partnership which represents hope for patients to finally get a real treatment,” said Dr Annick Antierens, spokesperson for MSF.
In the interim, Liberia’s President Ellen Johnson Sirleaf has said that she has lifted the state of emergency in that country despite the fact that the war against Ebola is not over and the plea for international help from West Africa, the UN and WHO continues.
The Ebola outbreak is reported to have sickened as many as 14,000 people mostly in West Africa with over 5000 dead including over 100 health care workers. Just recently a nurse died in Mali awakening fears that Mali may still have a fight on its hands against the deadly disease.